Every month your FDA submission is delayed is costing you more than time — it’s burning capital, weakening your market position, and increasing investor risk in ways most MedTech teams underestimate. You already know regulatory delay is bad. But most founding teams treat it like a weather event — unfortunate, outside your control, something to …
In MedTech, an unexplained answer is a dangerous one. Traditional AI often provides results without a rationale. This leaves clinical and regulatory teams to fill in the blanks. QualiVerse champions Explainable AI (XAI) to ensure every output is backed by a clear, human-readable logic.
As a Physician-led Al-enabled SaMD, we relied on QMB for all our regulatory compliance needs. What differentiate them above the rest is QualiVerse. QualiVerse was able to expedite selecting our product code, predicate device, and design planning documents in a record time for pre-submission with the FDA. This also augmented our investment efforts.
